pharma · Osteoarthritis · Osteoporosis
Nordic Bioscience
Nordic Bioscience A/S
Nordic Bioscience A/S is a pharma organization headquartered in Herlev, DK. Primary therapeutic focus areas include Osteoarthritis, Osteoporosis, Ovarian cancer, Advanced prostate cancer, Atopic dermatitis. NovaPharmaNew
Herlev, DK HQ
1991 Founded
228 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Herlev, DK
- Founded
- 1991
- Employees
- 228
- Programs
- 5
- Drugs
- 10
- Patents
- 0
Teverelix TFA
Phase 2 · small molecule · Advanced prostate cancer
Teverelix TFA for Advanced prostate cancer is a Phase 2 program (small_molecule) at Nordic Bioscience A/S with 1 ClinicalTrials.gov record(s).
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Nordic Bioscience A/S
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Advanced prostate cancer
- Status
- active
- Trials
- 1